The pivotal role of XCL1 in activation of osteoclasts and osteoblasts highlights it as a therapeutic target for aseptic loosening and other diseases associated with bone destruction such as rheumatoid arthritis, Paget's disease, cancer bone metastases, and osteoporosis. This evidence concerns the gene XCL1 and osteoporosis.